Hostname: page-component-78c5997874-mlc7c Total loading time: 0 Render date: 2024-11-10T06:09:03.894Z Has data issue: false hasContentIssue false

Healthcare-Associated Staphylococcus aureus Bacteremia and the Risk for Methicillin Resistance: Is the Centers for Disease Control and Prevention Definition for Community-Acquired Bacteremia Still Appropriate?

Published online by Cambridge University Press:  21 June 2016

Olivier Lesens*
Affiliation:
Service des Maladies Infectieuses et Tropicales, Hôtel-Dieu, Clermont-Ferrand, France
Yves Hansmann
Affiliation:
Service des Maladies Infectieuses et Tropicales, Clinique Médicale A, Hôpitaux Universitaires, Strasbourg, France
Eimar Brannigan
Affiliation:
Genitourinary Medicine and Infectious Diseases Department, Dublin, Ireland
Susan Hopkins
Affiliation:
Genitourinary Medicine and Infectious Diseases Department, Dublin, Ireland
Pierre Meyer
Affiliation:
Laboratoire de biostatistique, Faculté de Médecine, Strasbourg, France
Brian O'Connel
Affiliation:
Department of Microbiology, St. James Hospital, Dublin, Ireland
Gilles Prévost
Affiliation:
Service de bactériologie, Faculté de Médecine, Strasbourg, France
Colm Bergin
Affiliation:
Genitourinary Medicine and Infectious Diseases Department, Dublin, Ireland
Daniel Christmann
Affiliation:
Service des Maladies Infectieuses et Tropicales, Clinique Médicale A, Hôpitaux Universitaires, Strasbourg, France
*
Service des Maladies Infectieuses et Tropicales, Hôtel-Dieu, CHU, 63000 Clermont-Ferrand, France. olivier.lesens@wanadoo.fr

Abstract

Objective:

To evaluate a new classification for bloodstream infections that differentiates hospital acquired, healthcare associated, and community acquired in patients with blood cultures positive for Staphylococcus aureus.

Design:

Prospective, observational study.

Setting:

Three tertiary-care, university-affiliated hospitals in Dublin, Ireland, and Strasbourg, France.

Patients:

Two hundred thirty consecutive patients older than 18 years with blood cultures positive for S. aureus.

Methods:

S. aureus bacteremia (SAB) was defined as hospital acquired if the first positive blood culture was performed more than 48 hours after admission. Other SABs were classified as healthcare associated or community acquired according to the definition proposed by Friedman et al. When available, strains of methicillin-resistant Staphylococcus aureus (MRSA) were analyzed by pulsed-field gel electrophoresis (PFGE).

Results:

Eighty-two patients were considered as having community-acquired bacteremia according to the Centers for Disease Control and Prevention (CDC) classification. Of these 82 patients, 56% (46) had healthcare-associated SAB. MRSA prevalence was similar in patients with hospital-acquired and healthcare-associated SAB (41% vs 33%; P > .05), but significantly lower in the group with community-acquired SAB (11%; P < .03). PFGE of MRSA strains showed that most community-acquired and healthcare-associated MRSA strains were similar to hospital-acquired MRSA strains. On multivariate analysis, Friedman's classification was more effective than the CDC classification for predicting MRSA.

Conclusion:

These results support the call for a new classification for community-acquired bacteremia that would account for healthcare received outside the hospital by patients with SAB.

Type
Original Articles
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2005

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Voss, A, Milatovic, D, Wallrauch-Schwarz, C, et al.Methicillin-resistant Staphylococcus aureus in Europe. Eur J Clin Microbiol Infect Dis 1994; 13:5055.CrossRefGoogle ScholarPubMed
2.Melzer, M, Eykyn, SJ, Gransden, WR, Chinn, S. Is methicillin-resistant Staphylococcus aureus more virulent than methicillin-susceptible S. aureus? A comparative cohort study of British patients with nosocomial infection and bacteremia. Clin Infect Dis 2003;37:14531460.CrossRefGoogle ScholarPubMed
3.Lesens, O, Méthlin, C, Hansmann, Y, et al.Role of comorbidity in mortality related to Staphylococcus aureus bacteremia: a prospective study using the Charlson weighted index of comorbidity. Infect Control Hosp Epidemiol 2003;24:890896.CrossRefGoogle ScholarPubMed
4.Salgado, CD, Farr, BM, Calfee, DP. Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors. Clin Infect Dis 2003;36:131139.CrossRefGoogle ScholarPubMed
5.Garner, JS, Jarvis, WR, Emori, TG, Horan, TC, Hughes, JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988;16:128140.CrossRefGoogle ScholarPubMed
6.Friedman, ND, Kaye, KS, Stout, JE, et al.Health-care associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 2002;137:791797.CrossRefGoogle ScholarPubMed
7.Charlson, ME, Pompei, P, Ales, KL, et al.A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. Journal of Chronic Diseases 1987;40:373383.CrossRefGoogle ScholarPubMed
8.Lesens, O, Hansmann, Y, Brannigan, E, et al.Positive surveillance blood culture is a predictive factor for metastatic infection in patients with Staphylococcus aureus bacteraemia. J Infect 2004;48:245252.CrossRefGoogle ScholarPubMed
9.Sekeres, MA, Abrutyn, E, Berlin, JA, et al.An assessment of the usefulness of the Duke criteria for diagnosing active infective endocarditis. Clin Infect Dis 1997;24:11851190.CrossRefGoogle ScholarPubMed
10.Lautenschlager, S, Herzog, C, Zimmerli, W. Course and outcome of bacteremia due to Staphylococcus aureus. Clin Infect Dis 1993;16:567573.CrossRefGoogle ScholarPubMed
11.Mylotte, JM, McDermott, C. Staphylococcus aureus bacteremia caused by infected intravenous catheters. Am J Infect Control 1987;15:16.CrossRefGoogle ScholarPubMed
12.Prevost, G, Jaulhac, B, Piemont, Y. DNA fingerprinting by pulsed-field gel electrophoresis is more effective than ribotyping in distinguishing among methicillin-resistant Staphylococcus aureus isolates. J Clin Microbiol 1992;30:967973.CrossRefGoogle ScholarPubMed
13.Morin, CA, Hadler, JL. Population-based incidence and characteristics of community-onset Staphylococcus aureus infections with bacteremia in 4 metropolitan Connecticut areas, 1998. J Infect Dis 2001;184:10291034.CrossRefGoogle ScholarPubMed
14.Mylotte, JM, McDermott, C, Spooner, JA. Prospective study of 114 consecutive episodes of Staphylococcus aureus bacteremia. Rev Infect Dis 1987;9:891907.CrossRefGoogle ScholarPubMed
15.Fowler, VG Jr, Sanders, LL, Sexton, DJ. Outcome of Staphylococcus aureus bacteremia according to compliance with recommendations of infectious diseases specialists: experience with 244 patients. Clin Infect Dis 1998;27:478486.CrossRefGoogle ScholarPubMed
16.Nolan, CM, Beaty, HN. Staphylococcus aureus bacteremia. Am J Med 1976;60:495500.CrossRefGoogle ScholarPubMed
17.Bayer, AS, Lam, K, Ginzton, L, Norman, DC, Chiu, CY, Ward, JLClinical, serologic, and echocardiographic findings in patients with and without endocarditis. Arch Intern Med 1987;147:457462.CrossRefGoogle ScholarPubMed
18.Lesens, O, Hansmann, Y, Storck, D, Christmann, D. Risk factors for metastatic infection in patients with Staphylococcus aureus bacteremia with and without endocarditis. European Journal of Internal Medicine 2003;14:227231.CrossRefGoogle ScholarPubMed
19.Fowler, VG, Li, J, Corey, R, et al.Role of echocardiography in evaluation of patients with Staphylococcus aureus bacteremia: experience in 103 patients. Journal of the American College of Cardiology 1997;30:10721078.CrossRefGoogle ScholarPubMed